Pulmonx (LUNG) Earnings Date & Reports

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LUNG is expected to report earnings to fall 14.67% to -28 cents per share on August 05

Q2'26

Est.

$-0.28

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.14

Q3'25

Beat

by $0.08

Q2'25

Beat

by $0.02

The last earnings report on April 29 showed earnings per share of -33 cents, beating the estimate of -34 cents. With 226.23K shares outstanding, the current market capitalization sits at 57.86M.

View a ticker or compare two or three

Compare

LUNG

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LUNG